Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced record-setting attendance and virtual

Related Keywords

Canada ,Brazil ,Brazilian ,Arlene Padron ,Jill Fiedler Kelly ,Shawn Oconnor ,Rajanikanth Madabushi ,Simulations Plus Resource Center ,Drug Administration ,Simulations Plus Inc ,Nasdaq ,Drug Development ,Exchange Commission ,Youtube ,Office Of Clinical Pharmacology ,Health Canada ,Simulations Plus ,Scientific Conference ,Associate Director ,Scientific Policy ,Clinical Pharmacology ,Model Informed Drug Development ,Integrative Approach ,United Kingdom ,Divisional President ,Simulations Plus Resource ,Harbor Statement Under ,Private Securities Litigation Reform Act ,